drugset / Trial / NCT06279533
Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is divided into two parts: the safety, tolerability, pharmacokinetic profiles of LV232 capsules after multiple ascending doses (hereinafter referred to as "PK characteristics of multiple ascending doses study ") and food effect study (hereinafter referred to as "FE study"). A total of 48 subjects are planned to be enrolled. The two parts of the study can be carried out simultaneously, and there is no order requirement.
Timeline
- Start
- 2024-02-27
- Primary completion
- 2024-12-17
- Completion
- 2024-12-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LV232 | Unknown | 15 mg | Oral |
| Subject | LV232 | Unknown | 20 mg | Oral |
| Subject | LV232 | Unknown | 40 mg | Oral |
| Subject | LV232 | Unknown | 60 mg | Oral |
Indications
No indication recorded.